Literature DB >> 15464035

Recent pharmacological studies on natural products in China.

Xing Zu Zhu1, Xiao-Yu Li, Jin Liu.   

Abstract

Natural products have been used as medicinal agents for many years. In addition, these compounds have also served as the starting points for semisynthetic analogs with improved properties. This review focuses on recent advances in the pharmacological studies on natural products mainly performed and published in China. Emphasis will be placed on those compounds that show the greatest promise clinically such as huperzine A (9-amino-13-ethylidene-11-methyl-4-azatricyclo[7.3.1.0(3.8)]trideca-3(8),6,11-trien-5-one), s-(-)-3-n-butylphthalide (s-(-)-3-butyl-1(3H)-isobenzofuranone), (-)-clausenamide (3-hydroxy-4-phenyl-5a-hydroxybenzyl-N-methyl-gamma-lactam) and Ginkgo biloba extract and its active components.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464035     DOI: 10.1016/j.ejphar.2004.07.027

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  20 in total

Review 1.  Endoplasmic reticulum stress: a novel mechanism and therapeutic target for cardiovascular diseases.

Authors:  Mei-qing Liu; Zhe Chen; Lin-xi Chen
Journal:  Acta Pharmacol Sin       Date:  2016-02-01       Impact factor: 6.150

Review 2.  Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae).

Authors:  Anita M Brinker; Jun Ma; Peter E Lipsky; Ilya Raskin
Journal:  Phytochemistry       Date:  2007-01-23       Impact factor: 4.072

3.  Berberine ameliorates pro-inflammatory cytokine-induced endoplasmic reticulum stress in human intestinal epithelial cells in vitro.

Authors:  Xianhua Hao; Anlong Yao; Jianfeng Gong; Weiming Zhu; Ning Li; Jieshou Li
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

4.  The edaravone and 3-n-butylphthalide ring-opening derivative 10b effectively attenuates cerebral ischemia injury in rats.

Authors:  Kai Hua; Xiao Sheng; Ting-ting Li; Lin-na Wang; Yi-hua Zhang; Zhang-jian Huang; Hui Ji
Journal:  Acta Pharmacol Sin       Date:  2015-06-15       Impact factor: 6.150

Review 5.  A Synopsis of Multitarget Potential Therapeutic Effects of Huperzine A in Diverse Pathologies-Emphasis on Alzheimer's Disease Pathogenesis.

Authors:  Mayuri Shukla; Prapimpun Wongchitrat; Piyarat Govitrapong
Journal:  Neurochem Res       Date:  2022-02-05       Impact factor: 3.996

6.  Berberine inhibits HIV protease inhibitor-induced inflammatory response by modulating ER stress signaling pathways in murine macrophages.

Authors:  Weibin Zha; Guang Liang; Jian Xiao; Elaine J Studer; Phillip B Hylemon; William M Pandak; Guangji Wang; Xiaokun Li; Huiping Zhou
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

7.  Triptolide protects against 1-methyl-4-phenyl pyridinium-induced dopaminergic neurotoxicity in rats: implication for immunosuppressive therapy in Parkinson's disease.

Authors:  Jun-Peng Gao; Shan Sun; Wen-Wei Li; Yi-Ping Chen; Ding-Fang Cai
Journal:  Neurosci Bull       Date:  2008-06       Impact factor: 5.203

8.  Berberine diminishes side population and down-regulates stem cell-associated genes in the pancreatic cancer cell lines PANC-1 and MIA PaCa-2.

Authors:  S H Park; J H Sung; N Chung
Journal:  Mol Cell Biochem       Date:  2014-06-04       Impact factor: 3.396

9.  New Perspectives on How to Discover Drugs from Herbal Medicines: CAM's Outstanding Contribution to Modern Therapeutics.

Authors:  Si-Yuan Pan; Shu-Feng Zhou; Si-Hua Gao; Zhi-Ling Yu; Shuo-Feng Zhang; Min-Ke Tang; Jian-Ning Sun; Dik-Lung Ma; Yi-Fan Han; Wang-Fun Fong; Kam-Ming Ko
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-24       Impact factor: 2.629

10.  Inhibition of P-glycoprotein by HIV protease inhibitors increases intracellular accumulation of berberine in murine and human macrophages.

Authors:  Weibin Zha; Guangji Wang; Weiren Xu; Xuyuan Liu; Yun Wang; Beth S Zha; Jian Shi; Qijin Zhao; Phillip M Gerk; Elaine Studer; Phillip B Hylemon; William M Pandak; Huiping Zhou
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.